Chronic heart failure(CHF) accompanied by higher comorbidity and mortality is increasing in line with advancing age. Previous landmark randomised clinical trials were mostly conducted in younger systolic HF patients with an average age of < 63 years and a left ventricular ejection fraction of < 40%. However， in “real world”，